Nutex Health Inc. (NUTX) vs Starling Oncology, Inc. (STLN)
- Nutex Health Inc. NUTX 185.95 −7.40%
- Starling Oncology, Inc. STLN 6.43 −6.95%
Nutex Health Inc. and Starling Oncology, Inc. are both Medical Care Facilities companies. Nutex Health Inc. is the larger, with a market value of $1.4B against $690.9M — 2.0× the size. Starling Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; Nutex Health Inc. trades at 7.1×. Starling Oncology, Inc. grew revenue faster over the last twelve months: 38.4% against 6.88%. Nutex Health Inc. has the higher net margin (21.3% vs −6.18%) and the higher return on invested capital (37.9% vs −117.7%). Across the 18 metrics below, Nutex Health Inc. leads on 10 and Starling Oncology, Inc. on 8.
Valuation
Profitability
| Metric | NUTX | STLN | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 51.26% | 15.69% | 30.78% |
| Operating margin | 43.02% | (4.44%) | 5.74% |
| Net margin | 21.25% | (6.18%) | 2.32% |
| Free cash flow margin | 32.38% | (0.56%) | 5.46% |
| Return on equity | 42.63% | 214.12% | 8.76% |
| Return on assets | 19.93% | (21.47%) | 2.18% |
| Return on invested capital | 37.92% | (117.66%) | 5.01% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack